141 related articles for article (PubMed ID: 15557111)
1. Mechanisms underlying reduced apoptosis in neonatal neutrophils.
Hanna N; Vasquez P; Pham P; Heck DE; Laskin JD; Laskin DL; Weinberger B
Pediatr Res; 2005 Jan; 57(1):56-62. PubMed ID: 15557111
[TBL] [Abstract][Full Text] [Related]
2. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.
Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D
Oncogene; 2003 Jul; 22(29):4543-56. PubMed ID: 12881711
[TBL] [Abstract][Full Text] [Related]
3. NGF-withdrawal induces apoptosis in pancreatic beta cells in vitro.
Pierucci D; Cicconi S; Bonini P; Ferrelli F; Pastore D; Matteucci C; Marselli L; Marchetti P; Ris F; Halban P; Oberholzer J; Federici M; Cozzolino F; Lauro R; Borboni P; Marlier LN
Diabetologia; 2001 Oct; 44(10):1281-95. PubMed ID: 11692177
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
Ochs K; Kaina B
Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-8-induced suppression of polymorphonuclear leukocyte apoptosis is mediated by suppressing CD95 (Fas/Apo-1) Fas-1 interactions.
Leuenroth S; Lee C; Grutkoski P; Keeping H; Simms HH
Surgery; 1998 Aug; 124(2):409-17. PubMed ID: 9706166
[TBL] [Abstract][Full Text] [Related]
6. BCL-2 family expression in human neutrophils during delayed and accelerated apoptosis.
Moulding DA; Akgul C; Derouet M; White MR; Edwards SW
J Leukoc Biol; 2001 Nov; 70(5):783-92. PubMed ID: 11698499
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells.
Walczak H; Bouchon A; Stahl H; Krammer PH
Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456
[TBL] [Abstract][Full Text] [Related]
8. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release.
Kandasamy K; Srinivasula SM; Alnemri ES; Thompson CB; Korsmeyer SJ; Bryant JL; Srivastava RK
Cancer Res; 2003 Apr; 63(7):1712-21. PubMed ID: 12670926
[TBL] [Abstract][Full Text] [Related]
9. Fas (Apo-1, CD95) receptor expression in childhood astrocytomas. Is it a marker of the major apoptotic pathway or a signaling receptor for immune escape of neoplastic cells?
Bodey B; Bodey B; Siegel SE; Kaiser HE
In Vivo; 1999; 13(4):357-73. PubMed ID: 10586378
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of resistance to TRAIL-induced apoptosis in cancer.
Zhang L; Fang B
Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937
[TBL] [Abstract][Full Text] [Related]
11. Anti-Fas antibody differentially regulates apoptosis in Fas ligand resistant carcinoma lines via the caspase 3 family of cell death proteases but independently of bcl2 expression.
Crowe DL; Boardman ML; Fong KS
Anticancer Res; 1998; 18(5A):3163-70. PubMed ID: 9858879
[TBL] [Abstract][Full Text] [Related]
12. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Yap D; Knox KA
Cell Immunol; 1997 Nov; 181(2):139-52. PubMed ID: 9398401
[TBL] [Abstract][Full Text] [Related]
13. Expression of FasR, Fas-L and Bcl-2 in CD4+ and CD8+ subpopulations of T lymphocytes in the cord blood of healthy full-term newborns, is gender of influence?
Wasiluk A; Ratomski K; Wnuczko K; Zak J; Szczepański M; Wysocka J; Jasińska EA
Adv Med Sci; 2009; 54(1):99-103. PubMed ID: 19482726
[TBL] [Abstract][Full Text] [Related]
14. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
15. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
16. IL-17 attenuates the anti-apoptotic effects of GM-CSF in human neutrophils.
Dragon S; Saffar AS; Shan L; Gounni AS
Mol Immunol; 2008 Jan; 45(1):160-8. PubMed ID: 17555818
[TBL] [Abstract][Full Text] [Related]
17. Expression of genes involved in initiation, regulation, and execution of apoptosis in human neutrophils and during neutrophil differentiation of HL-60 cells.
Santos-Beneit AM; Mollinedo F
J Leukoc Biol; 2000 May; 67(5):712-24. PubMed ID: 10811013
[TBL] [Abstract][Full Text] [Related]
18. Interferon-gamma induces apoptosis and expression of inflammation-related proteins in Chang conjunctival cells.
De Saint Jean M; Brignole F; Feldmann G; Goguel A; Baudouin C
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2199-212. PubMed ID: 10476784
[TBL] [Abstract][Full Text] [Related]
19. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
[TBL] [Abstract][Full Text] [Related]
20. Cholangiocarcinomas express Fas ligand and disable the Fas receptor.
Que FG; Phan VA; Phan VH; Celli A; Batts K; LaRusso NF; Gores GJ
Hepatology; 1999 Dec; 30(6):1398-404. PubMed ID: 10573518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
